Alison Van Dyke
Areas of Expertise:
- Surgical Pathology
- Cancer Epidemiology
- Developing Biospecimen Processes
- Cancer Biology
Dr. Alison Van Dyke joined the Data Quality, Analysis, and Interpretation Branch of the Surveillance Research Program (SRP) as Director of the SEER-linked Virtual Tissue Repository (VTR) Pilot Studies. For the VTR Pilot Studies, SRP works with SEER registries to obtain custom annotations of detailed treatment data for pancreas and female breast cancer cases which may have biospecimens available. The goal is to match unusual survival cases with more typical survival controls. Dr. Van Dyke also directs the Residual Tissue Repositories (RTRs). Operated by the SEER registries in Hawaii, Iowa, and Los Angeles, the RTRs collect tissue being discarded by hospital laboratories once the minimum requirement for retaining diagnostic tissue blocks, as set forth by the College of American Pathologists (CAP), has been met.
Prior to joining SRP, Dr. Van Dyke earned her MD/PhD from Wayne State University School of Medicine in 2011 with graduate training in cancer biology. Under the mentorship of Dr. Ann Schwartz, her doctoral research focused on the role of inflammation in non-small cell lung cancer among women and included SEER data. She completed postgraduate medical residency training in anatomic pathology at Yale-New Haven Hospital and surgical subspecialty training in thoracic pathology at the University of Pittsburgh Medical Center. In addition to being board certified in Anatomic Pathology by the American Board of Pathology, she is a Fellow of the CAP and serves as the SEER Liaison to the CAP Cancer Committee, which determines what and how tumor information will be reported in pathology reports.
Dr. Van Dyke completed a postdoctoral fellowship in the Infections and Immunoepidemiology Branch of the Division of Cancer Epidemiology & Genetics (DCEG). Working with Drs. Jill Koshiol and Eric Engels in DCEG, Dr. Van Dyke's postdoctoral research focused on the incorporation of surgical pathology in epidemiologic research. She utilized data from the NCI Cancer Cohort Consortium to investigate the epidemiology of biliary tract cancers. She was also the first researcher to use the digital slide collection from the National Lung Screening Trial to investigate the relationships between lung scarring characteristics and lung cancer development. In addition, she established pathology tissue collection and evaluation methods for Dr. Koshiol’s Chile Biliary Longitudinal Study (Chile BiLS). She is completing a NAACCR project examining biliary tract cancer incidence trends in the United States.